XRpro® non-destructively quantifies the elemental composition of molecules. Samples are excited with x-rays, making their atoms fluoresce with characteristic x-ray signals. XRpro® quantifies these x-ray signals to assess drug and protein behavior, including binding, activity, and post-translational modifications. All of this occurs in one second.
XRpro® improves drug development with low cost, high-throughput, completely label-free measurements:
- XRpro® provides both safety and efficacy measurements for compounds in single one second measurements.
- XRpro® is automated to characterize 1,000,000 compounds per month.
- XRpro® saves the typical user $500,000 per month by eliminating labels.
- XRpro® measures multiple on-target and off-target reactions simultaneously, collecting data efficiently and inexpensively.
- XRpro® measures binding and function of critical targets and cofactors.
- XRpro® quantifies post-translational modifications and cofactors, such as phosphorylation, sulfonation, ATP, and metals.
